<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
span.EmailStyle17
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Other than updated statistics, it looks like the White House ONDCP has nothing new for disposal info/policies in their 2012 National Drug Control Strategy report
(<a href="http://wpsd.bimedia.net/content/2012_ndcs.pdf">http://wpsd.bimedia.net/content/2012_ndcs.pdf</a>):
<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><b><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Disposal:
</span></b><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">As stated previously, 71 percent of individuals that reported that they had misused prescrip­tion drugs obtained the drugs from a friend or relative.84 This demonstrates
the importance of getting these unneeded or expired prescription drugs out of the home and properly disposed where they cannot harm people or the environment.<o:p></o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-left:.5in"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">The Secure and Responsible Drug Disposal Act of 2010 allowed for DEA to implement regulations on the disposal of controlled substances
by ultimate users, long term care facilities, and other authorized persons. Until the regulations are promulgated, DEA will arrange for communities to get rid of unneeded or expired prescription drugs through National Prescription Drug Take Back Days. These
Take Back Days have been one of the most successful aspects of the <i>Prescription Drug Abuse Prevention Plan</i>. As of December 2011, three Take Back Days have resulted in the collection and destruction of more than 498 tons of medications through this
initiative. The success of this initiative could not have been accom­plished without the combined efforts of more than 3,900 Federal, state, local, and tribal law enforcement agencies that sponsored more than 5,000 collection sites.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D">Burke<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us]
<b>On Behalf Of </b>Stevan Gressitt<br>
<b>Sent:</b> Tuesday, April 17, 2012 4:02 PM<br>
<b>To:</b> pharmwaste<br>
<b>Subject:</b> [Pharmwaste] 2012 ONDCP Strategy<o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><a href="http://www.wpsdlocal6.com/news/local/White-House-releases-21st-Century-drug-policy-strategy--147774225.html">http://www.wpsdlocal6.com/news/local/White-House-releases-21st-Century-drug-policy-strategy--147774225.html</a><br clear="all">
<br>
-- <br>
Stevan Gressitt, M.D.<br>
Faculty Associate, University of Maine Center on Aging<br>
Academic Member, Athens Institute for Education and Research<br>
Athens, Greece<br>
Founding Director, International Institute for Pharmaceutical Safety<br>
University of New England, College of Pharmacy<br>
Department of Pharmaceutical Sciences<br>
Associate Professor of Clinical Psychiatry<br>
University of New England, College of Osteopathic Medicine<br>
314 Clark Road<br>
Unity, Maine, 04988<br>
<a href="mailto:gressitt@gmail.com" target="_blank">gressitt@gmail.com</a> <br>
Cell: 207-441-0291<br>
<a href="http://www.benzos.une.edu" target="_blank">www.benzos.une.edu</a><br>
<a href="http://www.safemeddisposal.com" target="_blank">www.safemeddisposal.com</a><o:p></o:p></p>
</div>
</body>
</html>